Tolerability of prophylactic Lariam® regimens

Tropical Medicine and Parasitology

Volumn 44, Issue 3, 1993, Pages 257-265

  Boudreau, E ^a   Schuster, B ^a   Sanchez, J ^a   Novakowski, W ^a   Johnson, R ^a   Redmond, D ^a   Hanson, R ^a   Dausel, L ^a  

^a Fidelity Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; MEFLOQUINE;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; DIPLOPIA; DOUBLE BLIND PROCEDURE; DREAMING; DRUG BLOOD LEVEL; DRUG SAFETY; HEADACHE; HEART PALPITATION; HUMAN; HUMAN EXPERIMENT; INSOMNIA; IRRITABILITY; MALARIA CONTROL; MALE; MONITOR; MOOD; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLEEP DISORDER; SOLDIER; SOMNOLENCE; TRAVEL; VERTIGO;

ADULT; ANOREXIA; CHLOROQUINE; DEPRESSION; DIZZINESS; DOUBLE-BLIND METHOD; DREAMS; DRUG TOLERANCE; EYE; HUMAN; IRRITABLE MOOD; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MILITARY PERSONNEL; NAUSEA; PSYCHOMOTOR PERFORMANCE; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; TRAVEL; UNITED STATES;

EID: 0027518201     PISSN: 01772392     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)